As the world’s first molecular blood test for early detection of gastric cancer, GASTROClear is an HSA-approved Class C medical device that was launched as an IVD product in Singapore in 2019. It provides information on your risk of gastric cancer, and you can then manage your risks via regular screening for early detection, where treatment is more effective and less costly.